303 related articles for article (PubMed ID: 12008086)
1. In vitro characterization of hematopoietic microenvironment cells from patients with myelodysplastic syndrome.
Flores-Figueroa E; Gutiérrez-Espíndola G; Montesinos JJ; Arana-Trejo RM; Mayani H
Leuk Res; 2002 Jul; 26(7):677-86. PubMed ID: 12008086
[TBL] [Abstract][Full Text] [Related]
2. Assessment of stromal function, and its potential contribution to deregulation of hematopoiesis in the myelodysplastic syndromes.
Tauro S; Hepburn MD; Bowen DT; Pippard MJ
Haematologica; 2001 Oct; 86(10):1038-45. PubMed ID: 11602409
[TBL] [Abstract][Full Text] [Related]
3. Abnormalities of adherent layers grown from bone marrow of patients with myelodysplasia.
Tennant GB; Walsh V; Truran LN; Edwards P; Mills KI; Burnett AK
Br J Haematol; 2000 Dec; 111(3):853-62. PubMed ID: 11122147
[TBL] [Abstract][Full Text] [Related]
4. Cytokine expression in adherent layers from patients with myelodysplastic syndrome and acute myelogenous leukemia.
Wetzler M; Kurzrock R; Estrov Z; Estey E; Talpaz M
Leuk Res; 1995 Jan; 19(1):23-34. PubMed ID: 7837815
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal stem cells in myelodysplastic syndromes: phenotypic and cytogenetic characterization.
Flores-Figueroa E; Arana-Trejo RM; Gutiérrez-Espíndola G; Pérez-Cabrera A; Mayani H
Leuk Res; 2005 Feb; 29(2):215-24. PubMed ID: 15607371
[TBL] [Abstract][Full Text] [Related]
6. Marrow stroma in MDS: culprit or bystander?
Deeg HJ
Leuk Res; 2002 Jul; 26(7):687-8. PubMed ID: 12008087
[No Abstract] [Full Text] [Related]
7. Negative regulators of hemopoiesis and stroma function in patients with myelodysplastic syndrome.
Deeg HJ; Beckham C; Loken MR; Bryant E; Lesnikova M; Shulman HM; Gooley T
Leuk Lymphoma; 2000 Apr; 37(3-4):405-14. PubMed ID: 10752992
[TBL] [Abstract][Full Text] [Related]
8. The bone marrow stem stromal imbalance--a key feature of disease progression in case of myelodysplastic mouse model.
Das M; Chatterjee S; Basak P; Das P; Pereira JA; Dutta RK; Chaklader M; Chaudhuri S; Law S
J Stem Cells; 2010; 5(2):49-64. PubMed ID: 22049615
[TBL] [Abstract][Full Text] [Related]
9. Functional disturbance of marrow stromal microenvironment in the myelodysplastic syndromes.
Tauro S; Hepburn MD; Peddie CM; Bowen DT; Pippard MJ
Leukemia; 2002 May; 16(5):785-90. PubMed ID: 11986938
[TBL] [Abstract][Full Text] [Related]
10. Severe hematopoietic alterations in vitro, in bone marrow transplant recipients who develop graft-versus-host disease.
Martínez-Jaramillo G; Gómez-Morales E; Sánchez-Valle E; Mayani H
J Hematother Stem Cell Res; 2001 Jun; 10(3):347-54. PubMed ID: 11454310
[TBL] [Abstract][Full Text] [Related]
11. A systematic modeling study on the pathogenic role of p38 MAPK activation in myelodysplastic syndromes.
Peng H; Wen J; Zhang L; Li H; Chang CC; Zu Y; Zhou X
Mol Biosyst; 2012 Apr; 8(4):1366-74. PubMed ID: 22327869
[TBL] [Abstract][Full Text] [Related]
12. In vitro effects of IL-2 on NK-activity, clonogenic potential, blast cell proliferation and cytokine release of MDS bone marrow patients.
Cortelezzi A; Sarina B; Cattaneo C; Pomati M; Silvestris I; Soligo D; Calori R; Di Stefano M; Hu C; Monza M; Radelli L; Maiolo AT
Leukemia; 1996 Jul; 10(7):1181-9. PubMed ID: 8684000
[TBL] [Abstract][Full Text] [Related]
13. Blast colony forming cell-binding capacity of bone marrow stroma from myelodysplastic patients.
Gidáli J; Fehér I; Hollán SR
Stem Cells; 1996 Sep; 14(5):577-83. PubMed ID: 8888498
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of the in vitro proliferation and expansion of hematopoietic progenitors from patients with aplastic anemia and myelodysplasia.
Martínez-Jaramillo G; Flores-Figueroa E; Sánchez-Valle E; Gutiérrez-Espíndola G; Gómez-Morales E; Montesinos JJ; Flores-Guzmán P; Chávez-González A; Alvarado-Moreno JA; Mayani H
Leuk Res; 2002 Oct; 26(10):955-63. PubMed ID: 12163058
[TBL] [Abstract][Full Text] [Related]
15. [Abnormal polarization of T lymphocyte induces negative hematopoietic regulation in myelodysplastic syndromes].
Wu LY; Li X; Chang CK; Ying SX; Pu Q
Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):549-54. PubMed ID: 18078133
[TBL] [Abstract][Full Text] [Related]
16. Inappropriate Notch activity and limited mesenchymal stem cell plasticity in the bone marrow of patients with myelodysplastic syndromes.
Varga G; Kiss J; Várkonyi J; Vas V; Farkas P; Pálóczi K; Uher F
Pathol Oncol Res; 2007; 13(4):311-9. PubMed ID: 18158566
[TBL] [Abstract][Full Text] [Related]
17. Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes.
Shetty V; Mundle S; Alvi S; Showel M; Broady-Robinson L; Dar S; Borok R; Showel J; Gregory S; Rifkin S; Gezer S; Parcharidou A; Venugopal P; Shah R; Hernandez B; Klein M; Alston D; Robin E; Dominquez C; Raza A
Leuk Res; 1996; 20(11-12):891-900. PubMed ID: 9009245
[TBL] [Abstract][Full Text] [Related]
18. Impairment of GM-CSF production in myelodysplastic syndromes.
Visani G; Zauli G; Tosi P; Fogli M; Cenacchi A; Finelli C; Gamberi B; Ottaviani E; Manfoi S; Tura S
Br J Haematol; 1993 Jun; 84(2):227-31. PubMed ID: 8398822
[TBL] [Abstract][Full Text] [Related]
19. Functional characterization of fibroblastic cells in long-term marrow cultures from patients with acute myelogenous leukemia.
Mayani H; Guilbert LJ; Janowska-Wieczorek A
Leukemia; 1993 Oct; 7(10):1564-9. PubMed ID: 8412319
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic progenitor cells from patients with myelodysplastic syndromes: in vitro colony growth and long-term proliferation.
Flores-Figueroa E; Gutiérrez-Espindola G; Guerrero-Rivera S; Pizzuto-Chavez J; Mayani H
Leuk Res; 1999 Apr; 23(4):385-94. PubMed ID: 10229325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
